Former AstraZeneca commercial head Anthony "Tony" Zook was appointed CEO of obesity drug maker Vivus as expected now that the Mountain View, California-based company's largest investor First Manhattan Co (FMC) controls a majority of the Vivus board of directors seats.
After a bitter proxy battle in which Vivus fought to retain control of its nine-member board and FMC sought to replace the directors with its own nominees, the two sides negotiated a settlement on 18 July that gave the investment management firm six seats on an expanded 11-member board (scripintelligence.com,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?